Moxifloxacin vs Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Toxoid

## Moxifloxacin vs Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Toxoid: Overview

This comparison examines the pharmacological differences between **Moxifloxacin** and **Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Toxoid**.

## Mechanism of Action

**Moxifloxacin**: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

## Pharmacokinetics

**Half-life**: Moxifloxacin — 12 hours; Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Toxoid — N/A.

## Chemical Properties

**Molecular Formula**: Moxifloxacin — C21H24FN3O4; Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Toxoid — N/A.

**Molecular Weight**: Moxifloxacin — 401.4350 g/mol; Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Toxoid — N/A.

**Type**: Moxifloxacin — Small molecule; Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Toxoid — Vaccine component.